Breaking News Instant updates and real-time market news.

CTST

CannTrust

$3.20

0.955 (42.54%)

, EOLS

Evolus

$17.91

-0.25 (-1.38%)

09:10
08/12/19
08/12
09:10
08/12/19
09:10

Fly Intel: Pre-market Movers

UP AFTER EARNINGS: Evolus (EOLS), up 2%... Barrick Gold (GOLD), up 2%. DOWN AFTER EARNINGS: The Stars Group (TSG), down 1%. ALSO LOWER: CannTrust (CTST), down 28% after receiving a report from Health Canada notifying the company that its manufacturing facility in Vaughan, Ontario has been rated non-compliant with certain regulations... CooTek (CTK), down 13% after lowering Q2 guidance due to the difficulties that the company is experiencing in collecting its consideration from Google (GOOGL) and therefore the inability to recognize the corresponding advertising revenues for the last two months of the quarter as a result of Google's decision in mid-July to temporarily disable the company's global portfolio apps... NIO Inc. (NIO), down 3% after reporting July deliveries of 837 vehicles... Entercom (ETM), down 15% after lowering its quarterly dividend to 2c from 9c per share.

CTST

CannTrust

$3.20

0.955 (42.54%)

EOLS

Evolus

$17.91

-0.25 (-1.38%)

GOLD

Barrick Gold

$18.15

-0.04 (-0.22%)

TSG

The Stars Group

$15.98

0.39 (2.50%)

CTK

CooTek

$8.18

-0.13 (-1.56%)

NIO

NIO Inc.

$3.14

-0.045 (-1.41%)

ETM

Entercom

$3.55

0.1 (2.90%)

  • 12

    Aug

  • 12

    Aug

  • 12

    Aug

  • 15

    Aug

  • 20

    Aug

  • 04

    Sep

CTST CannTrust
$3.20

0.955 (42.54%)

07/08/19
07/08/19
DOWNGRADE

CannTrust downgraded to Neutral from Buy at Eight Capital
Eight Capital analyst Graeme Kreindler earlier today downgraded CannTrust Holdings to Neutral from Buy and lowered his price target for the shares to C$6 from C$11.
07/09/19
ROTH
07/09/19
DOWNGRADE
Target $4
ROTH
Neutral
CannTrust downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Scott Fortune downgraded CannTrust to Neutral from Buy, noting that the company has taken a "huge credibility hit" from the issued Health Canada non-compliance rating audit report, in which Health Canada has placed a hold on about 5,200 kg of dried cannabis. To be determined is Health Canada's enforcement response to what he deems a "flagrant lack of compliance" surrounding cultivating cannabis in five unlicensed rooms over a five-month timeframe. The analyst believes the operations misstep will have material impact to financials. Fortune also lowered his price target on the shares to $4 from $8.50.
07/08/19
BOFA
07/08/19
DOWNGRADE
Target $3.5
BOFA
Underperform
BofA double downgrades CannTrust to Underperform after Health Canada probe
BofA Merrill Lynch analyst Christopher Carey downgraded CannTrust two notches, to Underperform from Buy, and halved his price target on the shares $3.50 from $7 after the company announced that an audit from Health Canada found it had cultivated cannabis in rooms not yet licensed to do so and put a freeze on some of the company's inventory. Even following this morning's slide he expects the stock to remain weak due to uncertainty on the impact of the probe on CannTrust's financials as well as due to likely diminished investor confidence, said Carey. In morning trading in New York, CannTrust shares are down 92c, or 19%, to $4.02.
07/12/19
07/12/19
DOWNGRADE

CannTrust downgraded to Sell from Neutral at Eight Capital
Eight Capital analyst Graeme Kreindler downgraded CannTrust Holdings to Sell from Neutral and cut his price target for the shares to C$4 from C$6. The analyst downgraded the shares to Neutral on July 8.
EOLS Evolus
$17.91

-0.25 (-1.38%)

06/28/19
WELS
06/28/19
INITIATION
Target $16
WELS
Market Perform
Wells Fargo starts Evolus with Market Perform rating, $16 price target
Wells Fargo analyst David Maris initiated coverage of Evolus with a Market Perform rating and $16 price target. The analyst notes Evolus is early in the launch of its lead product Jeuveau and that the costs to attain market share may be significant. Further, he believes the company may need additional financing.
07/11/19
WELS
07/11/19
NO CHANGE
WELS
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
Most pharmaceuticals stocks are down today due to a number of factors, including reports that the Trump Administration is abandoning its plan to lower drug prices by eliminating or restricting pharmacy benefit manager rebating, Wells Fargo analyst David Maris tells investors in a research note. The analyst believes the market is correctly interpreting the move as a potential risk to drugmakers. The absence of a rebating fix "does not mean there will not be a plan to address drug prices, but perhaps a greater risk that the absence of a rebate fix will put additional pressure to come up with ways to actually lower prices in ways that could more greatly impact drug makers than the rebating fix would have," contends Maris. He points out that companies with large cash-pay components of their business, like Allergan (AGN), Establishment Labs (ESTA), Evolus (EOLS), GlaxoSmithKline (GSK), Perrigo (PRGO), Revance (RVNC) and Sientra (SIEN), do not seem to be under as much pressure today as some of their more generic or pharma-concentrated peers. Maris says his Outperform ratings on Allergan, Establishment and Sientra are in part due to their cash-pay concentration
07/11/19
WELS
07/11/19
NO CHANGE
Target $16
WELS
Market Perform
Evolus investors should keep eye on progressing Korean case, says Wells Fargo
A press report from Korea Biomedical Review indicates that the Seoul Central District Court has begun to test whether Nabota, the botulinum toxin of Daewoong Pharmaceutical, forms spores in the natural environment as an attempt to help decide the litigation between South Korean toxin manufacturers, Medytox and Daewoong, Wells Fargo analyst David Maris tells investors in a research note. Medytox sued Daewoong in 2017 alleging that Daewoong stole its botulinum toxin strain to manufacture its own, and thereby licensed U.S. cosmetic rights out to Evolus (EOLS) with a stolen botulinum toxin strain, Maris adds, while noting the report also said the first ruling should come in Q4 of this year. After speaking with company, Maris says the development is not unexpected. He believes, however, that investors should be aware of the progress and status of the litigation. The analyst keeps a Market Perform rating on Evolus shares with a $16 price target.
07/31/19
STFL
07/31/19
NO CHANGE
STFL
Buy
Physician survey bodes well for Evolus and Revance, says Stifel
Stifel analyst Annabel Samimy said her survey of 50+ physicians in late June lead her to now believe that new toxins could have penetrations that exceed her current market-share estimates. The survey bodes well for Evolus (EOLS) in the near-term and for both Evolus and Revance (RVNC) in the longer-term while also indicating that Allergan's (AGN) Botox franchise may be more vulnerable than previously thought, Samimy tells investors. She previously had Evolus' Jeuveau reaching a peak market share of 15% and Revance's DaxibotulinumtoxinA reaching 20% shares by 2027, but her new "base case" assumes that Jeuveau peaks at 20% share and Daxi peaks at 25%, noted Samimy, who took down her Botox market share forecast for 2027 to 50%. Samimy raised her price target on Evolus shares to $33 from $30 and keeps a $50 price target on Revance while maintaining Buy ratings on both stocks.
GOLD Barrick Gold
$18.15

-0.04 (-0.22%)

07/03/19
BMOC
07/03/19
UPGRADE
Target $20
BMOC
Outperform
Barrick Gold resumed with an Outperform from Market Perform at BMO Capital
BMO Capital analyst Andrew Kaip upgraded Barrick Gold (GOLD) to Outperform from Market Perform and raised his price target for the shares to $20 from $14.50 after resuming coverage of the name. The formation of the Nevada joint venture is a positive for Barrick as the synergies derived from consolidating the Nevada operations with Newmont Goldcorp (NEM) "unlock value," Kaip tells investors in a research note. The analyst this morning also downgraded Newmont Goldcorp to Market Perform from Outperform. He's confident the near-term benefits of the venture outweigh the risks for Barrick.
05/23/19
SBSH
05/23/19
NO CHANGE
Target $12.5
SBSH
Neutral
Citi upgrades Newmont, downgrades Barrick on resumption of coverage
Citi analyst Alexander Hacking resumed coverage of Barrick Gold and downgraded the shares to Neutral from Buy while lowering his price target to $12.50 from $14. He also resumed coverage of Newmont Mining (NEM) and upgraded the shares to Buy from Neutral while raising his price target for the shares to $40 from $36. The gold sector remains challenged, but Newmont offers better value than Barrick, Hacking tells investors in a research note. After applying Barrick's 1.2 times multiple to Newmont's holdings in the joint venture assets, the analyst sees Newmont's other assets trading at only 0.76 times net asset value. This could be re-rated higher as the market starts to incorporate the joint venture into models, says Hacking.
07/16/19
LEHM
07/16/19
DOWNGRADE
LEHM
Equal Weight
Barrick Gold downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Matthew Murphy downgraded Barrick Gold to Equal Weight from Overweight.
07/16/19
LEHM
07/16/19
DOWNGRADE
Target $18
LEHM
Equal Weight
Barrick Gold downgraded to Equal Weight on valuation at Barclays
Barclays analyst Matthew Murphy downgraded Barrick Gold to Equal Weight from Overweight while raising his price target for the shares to $18 from $15. The analyst cites valuation for the downgrade. While Murphy increased his gold multiples, he's "somewhat cautious of a retracement" and is "not calling for unbridled upside."
TSG The Stars Group
$15.98

0.39 (2.50%)

07/01/19
JPMS
07/01/19
INITIATION
Target $18
JPMS
Neutral
The Stars Group initiated with a Neutral at JPMorgan
JPMorgan analyst Omer Sander started The Stars Group with a Neutral rating and $18 price target. The analyst sees potential risks from the company's exposure to unregulated markets and says its strategy to expand into locally-taxed markets will likely pressure its EBITDA margins. He thinks the stock's valuation is fair at current levels.
07/01/19
DBAB
07/01/19
INITIATION
DBAB
Hold
The Stars Group initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Simon Davies started The Stars Group with a Hold rating and C$24 price target.
05/16/19
DESJ
05/16/19
DOWNGRADE
DESJ
Hold
The Stars Group downgraded to Hold from Buy at Desjardins
Desjardins analyst Maher Yaghi downgraded The Stars Group to Hold from Buy and lowered his price target on the shares to C$35 from C$37.50 following the company's Q1 earnings report.
05/16/19
05/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Occidental Petroleum (OXY) downgraded to Hold from Buy at Argus with analyst Bill Selesky citing its confirmed purchase of Anadarko Petroleum (APC) for $76 per share and saying the company is overpaying for the assets with a bid well above that of Chevron's (CVX) $65 per share offer. 2. Nomura (NMR) downgraded to Sell from Neutral at Citi with analyst Koichi Niwa saying he sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. 3. Sito Mobile (SITO) downgraded to Hold from Buy at Lake Street with analyst Mark Argento citing the company's "big" Q1 miss and said he sees uncertainty around Sito Mobile's new product strategy and liquidity concerns in the near term. 4. The Stars Group (TSG) downgraded to Hold from Buy at Desjardins. 5. Roan Resources (ROAN) downgraded to In-Line from Outperform at Imperial Capital with analyst Irene Haas saying the company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CTK CooTek
$8.18

-0.13 (-1.56%)

06/04/19
FBCO
06/04/19
DOWNGRADE
FBCO
Neutral
CooTek downgraded to Neutral from Outperform at Credit Suisse
03/08/19
SBSH
03/08/19
DOWNGRADE
SBSH
Neutral
CooTek downgraded to Neutral from Buy at Citi
06/10/19
SBSH
06/10/19
DOWNGRADE
Target $7.5
SBSH
Sell
CooTek downgraded to Sell from Neutral at Citi
Citi analyst Alicia Yap downgraded CooTek to Sell from Neutral with a reduced price target of $7.50. The analyst sees macro headwinds for the company and says its execution on the strategy shift is "unproven."
07/17/19
BOFA
07/17/19
DOWNGRADE
BOFA
Underperform
CooTek downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Emerson Chan downgraded CooTek (CTK) to Underperform from Buy, citing headwinds seen following news that Google (GOOGL) is banning CooTek from its Play store and ad platforms.
NIO NIO Inc.
$3.14

-0.045 (-1.41%)

04/04/19
04/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris saying investors will continue to gain comfort with the incremental financial risk created by Facebook's content and privacy concerns. 2. NIO Inc. (NIO) upgraded to Buy from Neutral at Citi and to Neutral from Underperform at BofA/Merrill. 3. Ingersoll-Rand (IR) upgraded to Buy from Neutral at BofA/Merrill with analyst Andrew Obin citing premium core and earnings growth. 4. EOG Resources (EOG) upgraded to Buy from Hold at Tudor Pickering. 5. Signature Bank (SBNY) upgraded to Overweight from Neutral at JPMorgan with analyst Steven Alexopoulos raising his price target for the shares to $150 from $133. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/29/19
05/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Mills (GIS) downgraded to Sell from Neutral at Goldman Sachs with analyst Jason English saying that after a period of outperformance from sequential improvement in the company's core business and the impact of its acquisition of Blue Buffalo, General Mills is entering its next "chapter" of "mounting deceleration." 2. NIO Inc. (NIO) downgraded to Underperform from Neutral at BofA/Merrill with analyst Ming Hsun Lee saying he expects weak orders for the ES8 and ES6 due to EV purchase subsidy cuts, less cash flow from reduced car sales, increased competition from Tesla's (TSLA) Model 3 in 2020, and views valuation as "rich." 3. American Campus (ACC) downgraded to Market Perform from Outperform at JMP Securities with analyst Aaron Hecht saying his firm's checks at UC Berkeley indicate that the 6,000 bed RFP will likely end up being fee-based development, which takes one of his previously expected catalysts off the table. 4. Atlassian (TEAM) downgraded to Neutral from Buy at BTIG with analyst Edward Parker saying after a "great run" of over 100% in the last 12 months, the risk-reward on the stock has turned more "balanced." 5. Ericsson (ERIC) downgraded to Sell from Neutral at New Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/28/19
BOFA
05/28/19
DOWNGRADE
BOFA
Underperform
NIO Inc. downgraded to Underperform from Neutral at BofA/Merrill
05/29/19
05/29/19
DOWNGRADE
Target $3

Underperform
NIO Inc. downgraded to Underperform on shipment downside at BofA/Merrill
As previously reported, BofA/Merrill downgraded NIO Inc. (NIO) to Underperform from Neutral and cut its price target to $3 from $6.20. Analyst Ming Hsun Lee expects weak orders for the ES8 and ES6 due to EV purchase subsidy cuts, less cash flow from reduced car sales, increased competition from Tesla's (TSLA) Model 3 in 2020, and views valuation as "rich." Lee lowered his volume sales forecast for 2019 by 20% to 27k units and 2020 by 45% to 40k units.
ETM Entercom
$3.55

0.1 (2.90%)

11/01/18
GUGG
11/01/18
INITIATION
Target $8.5
GUGG
Buy
Entercom initiated with a Buy at Guggenheim
Guggenheim analyst Curry Baker initiated Entercom with a Buy and $8.50 price target.
12/07/18
WOLF
12/07/18
INITIATION
Target $8
WOLF
Outperform
Entercom initiated with an Outperform at Wolfe Research
Wolfe Research initiated Entercom with an Outperform and $8 price target.

TODAY'S FREE FLY STORIES

SMSEY

Samsonite International

$0.00

(0.00%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Samsonite International management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

URBN

Urban Outfitters

$23.91

1.53 (6.84%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Urban Outfitters management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Nov

SERV

ServiceMaster

$58.21

0.37 (0.64%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
ServiceMaster management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
Breaking General news story  »

Federal Reserve Chairman…

GLOB

Globant

$96.92

3.21 (3.43%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Globant management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
New Home Sales to be reported at 10:00 »

July New Home Sales will…

GKOS

Glaukos

$61.31

-1.71 (-2.71%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Glaukos management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 26

    Aug

  • 04

    Sep

  • 13

    Nov

AMAT

Applied Materials

$47.04

0.21 (0.45%)

, AMD

AMD

$31.90

0.2 (0.63%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$47.04

0.21 (0.45%)

AMD

AMD

$31.90

0.2 (0.63%)

ANET

Arista Networks

$227.19

0.48 (0.21%)

CHKP

Check Point

$109.20

-0.01 (-0.01%)

CSCO

Cisco

$48.20

-0.59 (-1.21%)

EQIX

Equinix

$554.08

2.15 (0.39%)

FLEX

Flex

$10.26

0.26 (2.60%)

INTC

Intel

$46.76

-0.39 (-0.83%)

NVDA

Nvidia

$171.44

0.21 (0.12%)

OTEX

OpenText

$39.11

0.18 (0.46%)

PYPL

PayPal

$108.74

-1.09 (-0.99%)

RNG

RingCentral

$142.36

2.33 (1.66%)

SQ

Square

$64.65

-0.78 (-1.19%)

STX

Seagate

$47.58

0.36 (0.76%)

TWLO

Twilio

$130.48

-0.57 (-0.43%)

V

Visa

$180.15

-0.8 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Global Pharma Analyst…

04:55
08/23/19
08/23
04:55
08/23/19
04:55
General news
Breaking General news story  »

Week of 8/23 Baker-Hughes…

CMS

CMS Energy

$62.13

0.04 (0.06%)

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
CMS Energy management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 10

    Nov

04:55
08/23/19
08/23
04:55
08/23/19
04:55
Conference/Events
Cowen retail analysts to hold an analyst/industry conference call »

Retail Analyst Chen,…

03:50
08/23/19
08/23
03:50
08/23/19
03:50
General news
FX Action: USD-CAD nudged out a three-day high »

FX Action: USD-CAD nudged…

03:05
08/23/19
08/23
03:05
08/23/19
03:05
General news
FX Update: The New Zealand dollar outperformed and China's yuan weakened »

FX Update: The New…

LLY

Eli Lilly

$111.63

0.2 (0.18%)

21:03
08/22/19
08/22
21:03
08/22/19
21:03
Hot Stocks
Arbitration panel rules in favor of Eli Lilly in Adocia IP claim »

A Chicago-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

, HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

20:25
08/22/19
08/22
20:25
08/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FL

Foot Locker

$42.00

2.24 (5.63%)

HIBB

Hibbett Sports

$17.01

0.845 (5.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

, AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

19:40
08/22/19
08/22
19:40
08/22/19
19:40
Hot Stocks
Trump 'hopeful' to work with Congress on' legislation addressing mass shootings »

President Donald Trump…

RGR

Sturm, Ruger

$41.48

0.69 (1.69%)

AOBC

American Outdoor Brands

$7.69

-0.01 (-0.13%)

VSTO

Vista Outdoor

$5.33

0.26 (5.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 10

    Sep

  • 19

    Sep

TOT

Total

$48.98

-0.18 (-0.37%)

19:16
08/22/19
08/22
19:16
08/22/19
19:16
Downgrade
Total rating change at Citi »

Total downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPR

Kemper

$75.42

0.48 (0.64%)

19:14
08/22/19
08/22
19:14
08/22/19
19:14
Downgrade
Kemper rating change at William Blair »

Kemper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

CRM

Salesforce

$148.26

0.86 (0.58%)

, INTU

Intuit

$276.05

-0.29 (-0.10%)

18:52
08/22/19
08/22
18:52
08/22/19
18:52
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

CRM

Salesforce

$148.26

0.86 (0.58%)

INTU

Intuit

$276.05

-0.29 (-0.10%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

RAVN

Raven

$31.36

-0.87 (-2.70%)

VMW

VMware

$148.15

0.11 (0.07%)

ROST

Ross Stores

$107.31

1.63 (1.54%)

GPS

Gap

$17.75

0.79 (4.66%)

HAS

Hasbro

$114.35

-1.06 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

  • 12

    Dec

  • 16

    Dec

TLND

Talend

$39.24

0.12 (0.31%)

18:45
08/22/19
08/22
18:45
08/22/19
18:45
Hot Stocks
Talend CEO: We solve the first mile in the data journey »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$354.47

14.44 (4.25%)

18:40
08/22/19
08/22
18:40
08/22/19
18:40
Periodicals
FAA intends to test Boeing MAX software on newer pilots, Reuters says »

Next month, the FAA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

DB

Deutsche Bank

$7.17

0.155 (2.21%)

18:32
08/22/19
08/22
18:32
08/22/19
18:32
Periodicals
Deutsche Bank to pay $16M to settle corruption charges with SEC, Reuters says »

The SEC said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$292.36

-0.04 (-0.01%)

18:28
08/22/19
08/22
18:28
08/22/19
18:28
Periodicals
Kudlow says U.S., Chinese negotiators held productive trade talks, Reuters says »

White House economic…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$292.36

-0.04 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

, GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

18:25
08/22/19
08/22
18:25
08/22/19
18:25
Hot Stocks
Google disabled 210 YouTube channels related to ongoing Hong Kong protests »

Google (GOOG) said in a…

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

FB

Facebook

$182.08

-1.48 (-0.81%)

TWTR

Twitter

$42.17

-0.63 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.